NCT00003068View on ClinicalTrials.gov

High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 1997

Study Completion Date

November 30, 2002

Conditions
Breast CancerDrug/Agent Toxicity by Tissue/Organ
Interventions
DRUG

amifostine trihydrate

DRUG

cyclophosphamide

DRUG

mitoxantrone hydrochloride

DRUG

thiotepa

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

85724

Arizona Cancer Center, Tucson

All Listed Sponsors
lead

University of Arizona

OTHER

NCT00003068 - High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer | Biotech Hunter | Biotech Hunter